[ Price : $8.95]
Pew Charitable Trusts calls on HHS to reinstate FDAs authority to require premarket reviews for laboratory-developed tests.[ Price : $8.95]
FDA says it is working with manufacturers of transmucosal immediate-release fentanyl products to ease provider and pharmacy recert...[ Price : $8.95]
FDA grants priority review to a Takeda NDA for mobocertinib to treat some lung cancers.[ Price : $8.95]
Amgen agrees to an FDA-proposed post-marketing requirement to conduct a multi-center randomized clinical trial to compare the safe...[ Price : $8.95]
A Compounding Pharmacy Foundation-funded report says FDA should ignore a National Academies report on the safety and efficacy of c...[ Price : $8.95]
The 3/17 MDUFA 5 reauthorization FDA/industry meeting covered seven topics summarized by the agency.[ Price : $8.95]
An FDA advisory committee votes to recommend the continuance of Genentechs accelerated approval for Tecentriq (atezolizumab) plus ...[ Price : $8.95]
FDA says Hope Biosciences Stem Cell Research Foundation can conduct a Phase 2 trial of multiple infusions of stem cells in patient...